• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of brjopthalBritish Journal of OphthalmologyCurrent TOCInstructions for authors
Br J Ophthalmol. Apr 1996; 80(4): 332–336.
PMCID: PMC505460

Causes and frequency of blindness in patients with intraocular inflammatory disease.


AIMS/BACKGROUND: Uveitis, an intraocular inflammatory disease, is a significant cause of visual impairment. It is not known how many patients with uveitis will retain visual acuity and how many develop visual impairment or even blindness. The aim of this study was to assess the frequency of blindness in patients with uveitis and, more specifically, to identify the clinical profile of patients at risk for visual loss. METHODS: A cross sectional and retrospective study of 582 patients with uveitis who visited the ophthalmology departments of two university hospitals in the Netherlands was performed. RESULTS: Within the group of 582 patients, 203 (35%) exhibited blindness or visual impairment; bilateral legal blindness developed in 22 (4%) patients, 26 (4.5%) had one blind eye with visual impairment of the other, and nine (1.5%) had bilateral visual impairment. Unilateral blindness developed in 82 (14%) patients, whereas 64 (11%) exhibited unilateral visual impairment. The most important cause of both blindness and visual impairment was cystoid macular oedema (29% and 41%, respectively). Complications of uveitis were encountered in more than half of the patients and 23% underwent one or more surgical procedures. When the patients were subdivided according to anatomical site, those with panuveitis had the worst visual prognosis. The systemic diseases associated with a poor visual prognosis were juvenile chronic arthritis and sarcoidosis. Ocular toxoplasmosis was the most frequent cause of unilateral visual loss. CONCLUSIONS: Cystoid macular oedema is the most frequent complication of uveitis and its occurrence plays a decisive role in the visual outcome of this disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1013K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990 Oct;14(5-6):303–308. [PubMed]
  • Forrester JV. Uveitis: pathogenesis. Lancet. 1991 Dec 14;338(8781):1498–1501. [PubMed]
  • Ronday MJ, Stilma JS, Barbe RF, Kijlstra A, Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol. 1994 Sep;78(9):690–693. [PMC free article] [PubMed]
  • ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol. 1982 Jan 29;52(3-4):279–285. [PubMed]
  • Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987 Feb 15;103(2):234–235. [PubMed]
  • Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994 Feb;101(2):389–396. [PubMed]
  • Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, Luyendijk L, Kijlstra A. Uveitis and systemic disease. Br J Ophthalmol. 1992 Mar;76(3):137–141. [PMC free article] [PubMed]
  • Rothova A, van Knapen F, Baarsma GS, Kruit PJ, Loewer-Sieger DH, Kijlstra A. Serology in ocular toxoplasmosis. Br J Ophthalmol. 1986 Aug;70(8):615–622. [PMC free article] [PubMed]
  • Lightman S. Uveitis: management. Lancet. 1991 Dec 14;338(8781):1501–1504. [PubMed]
  • Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989 Aug;72(3-4):287–296. [PubMed]
  • Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed]
  • McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994 Jan;18(1):38–72. [PubMed]
  • McCabe R, Remington JS. Toxoplasmosis: the time has come. N Engl J Med. 1988 Feb 4;318(5):313–315. [PubMed]
  • Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol. 1994 Jan;11(1):57–62. [PubMed]
  • Rothova A, van Veenedaal WG, Linssen A, Glasius E, Kijlstra A, de Jong PT. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987 Feb 15;103(2):137–145. [PubMed]
  • Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994 Jul;101(7):1267–1274. [PubMed]
  • de Boer JH, Luyendijk L, Rothova A, Baarsma GS, de Jong PT, Bollemeijer JG, Rademakers AJ, Van der Lelij A, Zaal MJ, Kijlstra A. Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol. 1994 Feb 15;117(2):201–210. [PubMed]
  • Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987 Oct;94(10):1242–1248. [PubMed]
  • Weiss H, Annesley WH, Jr, Shields JA, Tomer T, Christopherson K. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979 Feb;87(2):133–142. [PubMed]
  • Laatikainen L, Erkkilä H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh) 1981 Oct;59(5):707–718. [PubMed]
  • Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980 Jan;89(1):31–45. [PubMed]
  • Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol. 1988 Sep;72(9):646–659. [PMC free article] [PubMed]
  • Mamo JG. The rate of visual loss in Behçet's disease. Arch Ophthalmol. 1970 Oct;84(4):451–452. [PubMed]
  • Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong D u, Girard B, Rousselie F, Godeau P. Pronostic oculaire de la maladie de Behçet. J Fr Ophtalmol. 1992;15(5):343–347. [PubMed]
  • Hikichi T, Trempe CL. Role of the vitreous in the prognosis of peripheral uveitis. Am J Ophthalmol. 1993 Oct 15;116(4):401–405. [PubMed]
  • Diamond G. Ocular manifestations of genetic and developmental diseases. Curr Opin Ophthalmol. 1994 Dec;5(6):72–78. [PubMed]
  • Pruett RC, Brockhurst J, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol. 1974 Apr;77(4):448–453. [PubMed]
  • Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc U K. 1976 Apr;96(1):151–157. [PubMed]
  • Dick AD. The treatment of chronic uveitic macular oedema. Br J Ophthalmol. 1994 Jan;78(1):1–2. [PMC free article] [PubMed]
  • Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994 Jul;78(7):549–554. [PMC free article] [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...